before and after ghk cu “Is GHK-Cu actually worth it?” is genuinely one of the most common questions in my comments, so let me finally answer it properly., The short version: copper peptides have real research behind them, Before vs. after 3 months

BPC-157 increases VEGFR2 expression in animal models, and VEGF/VEGFR2 pathways are active in approximately half of human cancers, including ovarian cancer, melanoma, and numerous other malignancies

Not exactly, but the two are complementary rather than mutually exclusive

Key for effective glycemic control , these syringes are also compatible with the most popular insulin medications , such as Humalog, Novolog, Lantus, Levemir, and more

That makes his work relevant to BPC-157 identity, nomenclature, and pathway-focused article framing

One honest caveat up front Most BPC-157 evidence is preclinical, and human data remains limited as of July 2026